JSH practical guidelines for hematological malignancies, 2018: I. Leukemia—2. Acute promyelocytic leukemia (APL) Hiroyuki FujitaYuichi IshikawaYasuhisa Yokoyama Guideline 28 April 2020 Pages: 747 - 760
Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients Xuan ZhouMeihong ZhengJuan Li Original Article 13 February 2020 Pages: 761 - 770
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes Satoko OkaKazuo OnoMasaharu Nohgawa Original Article 11 March 2020 Pages: 771 - 778
Plasma-derived factors VIIa and X mixtures (Byclot®) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients Satoshi OchiMasahiro TakeyamaKeiji Nogami Original Article 06 February 2020 Pages: 779 - 785
Establishment of a megakaryoblastic cell line for conventional assessment of platelet calcium signaling Hiroshi SaitoMorisada HayakawaTsukasa Ohmori Original Article 16 March 2020 Pages: 786 - 794
Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia Tomas SimurdaJana ZolkovaPeter Kubisz Original Article 12 March 2020 Pages: 795 - 802
A retrospective analysis of treatment outcomes in 45 patients with cardiac light-chain amyloidosis: a single-center experience in Japan Shin-ichi FuchidaDaisuke IdeChihiro Shimazaki Original Article 04 February 2020 Pages: 803 - 811
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line Masatoshi SakuraiShinichiro Okamotothe New TARGET investigators Original Article 09 March 2020 Pages: 812 - 825
Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients Yoshimichi KoutakeJun TaniguchiToshinobu Hayashi Original Article 09 March 2020 Pages: 826 - 832
Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors Shin-ichiro FujiwaraKazuhiko IkedaKazuo Muroi Original Article 14 March 2020 Pages: 833 - 839
Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan Ayumi FujimotoRitsuro SuzukiMasayuki Hino Original Article 14 March 2020 Pages: 840 - 850
LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders Jian HongJing NiQingsheng Li Original Article 11 March 2020 Pages: 851 - 857
Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation Mai MizusawaTakaaki KonumaArinobu Tojo Original Article 14 March 2020 Pages: 858 - 868
Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases Katsutsugu UmedaKohsuke Imaithe Inherited Disease Working Group of the Japan Society for Hematopoietic Cell Transplantation Original Article 12 February 2020 Pages: 869 - 876
Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients Jung Yoon ChoiHyoung Jin KangHee Young Shin Original Article 26 March 2020 Pages: 877 - 887
Hemophagocytic relapsed intramedullary plasmacytoma Tarek H. MouhieddineBart BarlogieJulie Teruya-Feldstein Case Report 03 January 2020 Pages: 888 - 890
Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient Reina TakedaTomohiro IshigakiArinobu Tojo Case Report 13 January 2020 Pages: 891 - 896
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy Hiroshi UreshinoShuichi KoaradaShinya Kimura Case Report 28 January 2020 Pages: 897 - 902
Does patient sex play a role in treatment-free remission in chronic myeloid leukemia? Hiroshi UreshinoKazuharu KamachiShinya Kimura Letter to the Editor 21 March 2020 Pages: 903 - 903
No sex-related difference in achievement of treatment-free remission following treatment with tyrosine kinase inhibitors in chronic myeloid leukemia Hiroki YamaguchiKoiti Inokuchiof the Kanto CML Study Group Letter to the Editor 31 March 2020 Pages: 904 - 904